Gerrit Dispersyn

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Marlborough, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Caitlin Kontulis, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gerrit Dispersyn

Form 4 holding President & CEO, Director

Phio Pharmaceuticals Corp.

Security class
Common stock, $0.0001 par value
Shares / value
212,327
Estimated value
$320,614
Report date
01 Mar 2022
Price
$1.51
Ownership
Direct

Insider Reports Filed by Gerrit Dispersyn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .